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Microbeads and microcapsules are container structures that are frequently used in 
biomedical applications. In this dissertation, we have sought to impart new functionalities 
to these particles, inspired by phenomena observed with biological cells. We have 
engineered polymer microparticles that recognize and respond to specific species from 
the surroundings (e.g. cells, polymer chains, metal ions). Three classes of new 
microparticles are reported, which are each reminiscent of a different type of biological 
cell in terms of recognition capabilities and response.  
 
In the first part of this dissertation, we create functionalized microbeads from the 
biopolymer, chitosan, and use these to selectively recognize and capture Circulating 
Tumor Cells (CTCs) from blood. The microbeads are functionalized with a protein 
(streptavidin) and packed into an array within a microfluidic device. Blood samples with 
biotin-labeled CTCs are flowed over the packed bed of chitosan beads. Similar to how 
macrophages adhere to foreign bacteria (i.e. antibody-antigen interactions), the 
streptavidin-labeled chitosan beads can selectively recognize and adhere to the biotin-
labeled CTCs. We show that such a packed bed of chitosan beads could serve as an 
 
 
inexpensive platform for customized capture of different rare cells (cancer cells, stem 
cells etc) from blood.  
 
In the next study, we develop a class of microbeads that undergo clustering 
(aggregation) in the presence of specific polymers. The inspiration for this comes from 
the cells (e.g., platelets) and polymers involved during the formation of blood clots. Our 
system consists of chitosan microbeads coated with cyclodextrins (sugar molecules with 
a hydrophobic binding pocket), which are then exposed to a polymer that is decorated 
with hydrophobic units. The particles bind to the polymer chains via hydrophobic 
interactions and in turn, the particles are induced to form clusters. Subsequently, the 
polymer precipitates and forms a matrix around the particle clusters, leading to a structure 
that is reminiscent of a blood clot (platelets enveloped by a mesh of fibrin chains).   
 
Lastly, we develop a class of microparticles that have the ability to selectively 
destroy other microparticles. The inspiration here is from the body’s immune system, 
where cells like the killer T cells selectively destroy cancer and virus infected cells 
without harming healthy cells. Towards this end, we synthesize two types of 
microparticles: chitosan capsules that contain the enzyme glucose oxidase (GOx), and 
beads of a different biopolymer, alginate that are crosslinked with copper (Cu2+) ions. 
The chitosan capsules enzymatically convert glucose from the surroundings into 
gluconate ions. When these capsules approach the alginate/Cu2+ beads, the gluconate ions 
chelate the Cu2+ ions, leading to the disintegration of the alginate beads. Other beads that 
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INTRODUCTION AND OVERVIEW 
 
1.1. PROBLEM DESCRIPTION AND MOTIVATION 
Through advances in scientific understanding and clever engineering, humankind 
has been able to mold and shape many facets of the world around them. Currently, there 
is a great deal of interest in engineering systems on smaller scales, i.e., in micro and 
nanotechnology.1,2 Although there has been tremendous progress in this area, man-made 
micro and nanomaterials are still nowhere as intricate and functional as the systems 
designed by nature. The biological cell is still the most complex and sophisticated micro-
nano machine ever created. An open question for researchers is whether it is possible to 
take inspiration from biology to bridge this gap between man-made and natural systems 
and thereby propel the next generation of micro/nanotechnology. 
 
At the interface of biology, materials science, and chemistry many research 
groups have focused on developing cellular mimetic structures, and “artificial cells” 
(frequently referred to as protocells) with varying degrees of complexity.3-6  In synthetic 
biology, this type of research employs a top-down approach using genetic engineering 
techniques and existing cell infrastructure in combination with synthetic components to 
manipulate complex functions associated with “life” (i.e. self replication).7 Others have 
taken a bottom-up approach using simpler building blocks to design more primitive 
protocells with more basic functions, employing both biotic (i.e. DNA, proteins) and 




protocells in the most basic form as a container at the microscale. The vast majority of 
research involving polymer microparticles has focused on end-user applications in areas 
such as cosmetics, chromatography, and drug delivery.10 However, a few research groups 
have used bio-inspired design in the development of novel functionalities and 
applications for microparticles.11,12  
 
Recently, the integration of microfluidic technology as a platform in microparticle 
synthesis has led to significant advancements in control over the size, shape, and 
functional properties of these particles.13,14  This additional level of control opens further 
possibilities towards advancing new kinds of microparticles.15 For example, cell-like 
compartments and hierarchal structures can now be mimicked through design of 
controlled double and triple emulsions.16 Microfluidic platforms are now ubiquitous and 
inexpensive: they can be implemented even with simple capillary tubing and do not 
require expertise in lithography or microfabrication.   
 
1.2. PROPOSED APPROACH 
What lessons can we learn from biology in the context of microparticle 
engineering? Two important observations to consider are the following:   
1) Biological cells are specialized in design and function (e.g. red blood cells can 
transport oxygen but cannot produce insulin; conversely cells in the pancreas can 




2) Cells are biochemically designed to have capabilities for specific (targeted) 
interactions with their own unique environments (e.g. immune cells can recognize 
and target specific pathogens in blood). 
   
In this dissertation we draw inspiration from biology to engineer microparticles that can 
selectively respond to their surroundings. Specifically, we design microparticles that can 
recognize and respond to particular species from their surroundings (e.g. cells, polymer 
chains, metal ions). These responses are designed to mimic functions associated with 
biological cells. Three examples of microbeads with bio-inspired recognition capabilities 
and functionalities are discussed in this work: 
  
 
Figure 1.1. Cell-selective microbeads of the biopolymer, chitosan are used for capturing 
rare cells from blood. The microbead surface is modified with streptavidin. Cells coated 







1.2.1. Particles Capable of Capturing Specific Biological Cells   
The surfaces of many biological cells are designed to selectively adhere to 
specific objects within their environment. For example, leuokocytes within the immune 
system can adhere to various micron-sized objects such as foreign cells (pathogens) or 
even to other leukocytes and endothelial cells.17 In Chapter 3, we develop polymer 
microparticles that can selectively adhere to a type of rare cells found in the blood of 
patients with metastatic cancer, called Circulating Tumor Cells (CTCs). The polymer 
microparticles are coated with the protein, streptavidin, which has the ability to recognize 
and adhere to objects coated with the small molecule, biotin. We first tag the CTCs with a 
biotinylated antibody and then flow it through a packed bed of the polymer 
microparticles within a microfluidic channel. The bound CTCs can then be detected by 
fluorescence microscopy (Figure 1.1). The concept of using a packed bed of custom-
synthesized particles can be further adapted for detecting other kinds of rare cells such as 
stem cells in blood.  
 
 
Figure 1.2.  Microbeads that cluster in the presence of an associating polymer (i.e., a 
polymer with a hydrophilic backbone and hydrophobic pendant groups). Once the cluster 
forms, the polymer forms a precipitate around the cluster. The overall structure resembles 






1.2.2. Particles that Cluster in the Presence of a Specific Polymer 
Next, in Chapter 4, we develop microparticles that mimic the cluster formation 
seen with platelets during blood clotting. Platelets are a specific class of cells present in 
blood. When a wound occurs, surface receptors on the platelets are reconfigured so that 
they become sticky to a water-soluble protein also present in blood, called fibrinogen. As 
a result, fibrinogen bridges platelets together to generate “platelet plugs” (weak clusters). 
At the same time, fibrinogen is polymerized into water-insoluble fibrin through activation 
of the enzyme thrombin. The precipitated fibrin forms a web that traps aggregates of 
platelets and surrounding red blood cells to form the blood clot.18 In our work, we coat 
polymer microbeads with a hydrophobic supramolecule called cyclodextrin. These beads 
bind specifically to a soluble polymer that contains hydrophobic pendant groups. The 
binding results in clusters of the microbeads, which resemble “platelet plugs”. 
Subsequently, we find that the polymer precipitates out of solution in real-time, forming a 
web around the clusters (Figure 1.2), and this web can also trap surrounding inert objects. 






Figure 1.3.  Killer capsules that can selectively target neighboring microbeads for 
destruction. Over time, the killer capsule releases molecules that remove the metal ion 
cross-links from the target microbead, thereby leading to its destruction.  
 
1.2.3. Particles Engineered to Destroy Other Particles 
Finally, in Chapter 5, we develop microparticles that can destroy a specific type 
of surrounding particle. The inspiration in this case is from the immune system, where 
cytotoxic T lymphocytes (also referred to as “killer T cells”) are able to selectively kill 
cells that are infected with pathogens and not harm the surrounding healthy cells in our 
body. In our work, we synthesize polymer capsules that contain an enzyme. In the 
presence of the substrate, glucose, the killer capsule releases a product that recognizes 
and chelates with metal ions. Correspondingly, we develop a second class of polymer 
bead that is crosslinked by the same metal ions. When the two particles are brought into 
close proximity, the product from the killer capsule ends up chelating the ions that 




1.3). Other particles that are not dependent on metal ions for their crosslinking are not 
affected in this process.  
 
1.3. SIGNIFICANCE OF THIS WORK 
The newly synthesized microparticles described in this dissertation are significant 
from two different standpoints: (1) the particles could have some direct applications in 
various technologies and (2) the studies lay a foundation for the design of biomimetic and 
bioinspired materials and processes.   
 
Direct applications for our particles include biological detection (assays), 
microrobotics, drug delivery and controlled release, and embolization in the context of 
treating internal hemorrhage. For instance, the functionalized microbeads in Chapter 3 
could provide an adaptable system for capturing and detecting rare cells in blood such as 
circulating tumor cells (CTCs) or stem cells. The microbead clustering system in Chapter 
4 could be used as embolic agents to treat internal hemorrhage. Finally, the concepts in 
Chapter 5 involving destruction of specific target particles could be adapted for the 
localized and targeted release of drugs or other solutes in the context of drug delivery.    
  
The larger significance of this thesis is in laying a foundation for the bioinspired 
design of complex microparticles. As emphasized earlier, the most “intelligent” and 
complex microsystems that currently exist have been designed by nature. Thus, endowing 
synthetic particles with “cell-like” functionalities could be a fruitful approach to guide 




that are reminiscent of those occurring during the blood clotting cascade or during the 
function of immune cells. In the coming years, as additional “cell-like” functionalities for 
microparticles are reported, such capabilities will hopefully be integrated to produce 
exceptionally “intelligent” and useful microparticles from what began as initially very 
simple building blocks. Finally, it is worth emphasizing that the starting materials used to 
synthesize our microparticles are all inexpensive and widely available, while the methods 
used for synthesis are also straightforward and easy to replicate. We therefore believe that 









This dissertation focuses on the development of polymer-based microparticles 
with new bio-inspired functionalities. In this Chapter, we begin with a brief introduction 
to the polymers, notably the biopolymers chitosan and alginate, which are used 
throughout our studies. We then discuss the interactions of these polymers with various 
small molecules (e.g. metal ions, cyclodextrins); this will be relevant for the development 
of microbeads with specialized functions. Finally, we discuss the basics of optical and 
fluorescence microscopy. 
 
2.1.  BIOPOLYMERS  
2.1.1. Chitosan  
Chitosan is derived from the deacytlation of chitin, a linear polysaccharide found 
in the hard exterior of insects and crustaceans.19 In terms of abundance, after cellulose, 
chitin is the world’s second most common biopolymer. However, chitin is insoluble in 
water, which limits use in potential applications. Through deacetylation of chitin, the 
water soluble derivative (chitosan) is formed. The free amine groups along the chitosan 
backbone, which were made available through deacetylation, are ionized under acidic 
conditons, allowing for solubility of chitosan in water.20 The protonation of the amine 
groups under acidic conditions also causes the chitosan backbone to have a net postive 




unit) sugars and the remaining N-acetyl-D-glucosamine sugars from the parent polymer, 
chitin.  The chemical structures of these sugars are shown in Figure 2.1.     
 
 
Figure 2.1. Structures of the monomer sugars in (a) chitin and (b) chitosan. The 
N-acetyl-D-glucsoamine sugar in chitin is deacetylated to generate the D-glucosamine 
sugar in chitosan.  
 
Chitosan is used in a variety of applications, ranging from tissue engineering to 
wound dressings to environmental remediation to drug delivery, due to its beneficial 
properties.19,20 It is not only a biodegradable and biocompatible polymer, but is also one 
of the few cationic biopolymers. This confers antibacterial properties to chitosan, which 
can be useful in tissue engineering and for wound dressings. Moreover, chitosan is 
inexpensive and readily available; the parent polymer, chitin, is often obtained from food 
processing waste (e.g. crab and shrimp shells).2 Additionally, many researchers have 
explored various chemical modifications in attempts to augment chitosan’s already 
existing functional properties.22,23 One type of modification is to graft hydrophobic 






Figure 2.2. Chemical Structure of hydrophobically-modified chitosan with C12 
hydrophobic tails. 
 
2.1.2. Hydrophobically-Modified Chitosan  
Chitosan can be easily modified due to the free amines that are available on each 
glucosamine sugar. This allows the synthesis of hydrophobically-modified chitosan (hm-
chitosan) to be fairly straighforward; the free amines can be targeted by reaction with 
n-alkyl-aldehdyes via reductive amination.24 In this reaction, the primary amine groups 
are converted into NH-R groups, where R is the n-alkyl moiety. In this study, C12 
hydrophobic tails were grafted to the chitosan chains as the n-alkyl moiety. The structure 
of hm-chitosan containing C12 hydrophobic tails is shown in Figure 2.2. A general 
procedure for synthesizing hm-chitosan with C12 tails involves the following steps. First, 
chitosan is dissolved in an acidic water-ethanol mixture and then exposed to n-dodecyl 
aldedehyde. Then sodium cyanoborohydride is added to complete the reductive 
amination reaction, which yields hm-chitosan. The hm-chitosan is then precipitated by 
increasing the pH with the addition of sodium hydroxide. Next, the precipitate is washed 
multiple times in ethanol and subsequently in deionized water to remove any residual 
unreacted sodium cyanoborohydride, which is highly toxic. The purified hm-chitosan 
percipitate is then vacuum dried, re-dissolved in acetic acid solution; this solution tends 




which serves as a useful qualitative indication that the modification of chitosan has been 
successful. The degree of hydrophobic substitution in the final product corresponds to the 
initial molar ratio of aldehdye to chitosan monomer(s). This stoichiometrically expected 
degree of hydrophobic substituion in the final product can be confirmed using NMR.  

 
Figure 2.3. Chemical Structure of sodium alginate (adapted from Javvaji25) 
 
2.1.3. Alginate  
Sodium alginate, which is derived from brown algae, is another common 
polysaccharide. Due to its ease of crosslinking, biocompatability, abundance, and low 
cost, alginate has been extensively studied as a biomaterial. Applications include wound 
healing, drug delivery, and cell transplantation for tissue engineering.26  Sodium alginate 
is a linear unbranched polymer made up of blocks of 1,4-linked -D mannuronic (M) and 
-L guluronic (G) residues.27 Figure 2.3 demonstrates a general chemical structure of 
sodium alginate. Unlike chitosan, alginate is an anionic biopolymer that can interact with 
positively charged ions. Specifically, G-blocks of adjacent linear polymer chains can be 
cross-linked through formation of “egg-box” junctions with multivalent cations (e.g. Ca2+, 




these egg-box junctions results in the conversion of liquid alginate solution into a cross-
linked alginate hydrogel. The strength and stiffness of these hydrogels are dependent on 
the concentrations of alginate and the multivalent cation, as well as on the type (source) 
of the alginate (because different sources of alginate have varying molecular weights and 
varying ratios of M/G content).28   
 
 
Figure 2.4. Schematic demonstrating gelation of alginate upon addition of calcium ions 





2.2. INTERACTIONS OF BIOPOLYMERS 
2.2.1.  Chitosan and Chemical Cross-linkers 
As mentioned earlier, native chitosan can be dissolved in acidic water. This 
polymer solution can be easily converted into a gel through chemical crosslinkers such as 
dialdehydes.29 In particular, glutaraldehyde is a crosslinker for chitosan that is both 
soluble in water and in oily liquids. Since our droplet generators (Chapters 3 and 4) 
involve use of a continuous oil phase to shear and stabilize the aqueous droplets, 
glutaraldehyde can be introduced in the oil phase and it can diffuse into the aqueous 
chitosan droplets and thereby crosslink them into crosslinked structures.30  
 
Figure 2.5. Schematic demonstrating the crosslinking of chitosan with glutaraldehyde 
(adapted from Macquarrie29). 
 
Chitosan solutions can also be gelled non-covalently using multivalent anions like 
sodium tripolyphosphate (TPP). In solution, the positively charged amino group (NH3
+) 
of chitosan and P3O10





2.2.2.  Hydrophobically Modified Chitosan and Cyclodextrins 
 
 
Figure 2.6. Truncated cone-shaped structure of cyclodextrin (adapted from Galant32). 
 
Cyclodextrins (CDs) are cyclic oligosaccharides, typically composed of 6-8 
-D-glucopyranose units, that form a rigid truncated cone-shaped structure with an 
internal cavity size of 5-8 Å, depending on the number of glucopyranose units.32 
Interestingly, all the hydroxyl groups are located on the outside of the molecular cavity, 
thereby creating a hydrophilic outer surface with a relatively hydrophobic inner cavity. 
These hydrophobic pockets, can form host-guest inclusion complexes with various 
hydrophobic guest molecules.33 It should be noted that binding between the cyclodextrin 
host and the guest hydrophobic molecule is through non-covalent interactions, allowing 







Figure 2.7. Effect of adding α-CD to a gel formed by combining blood with hm-chitosan. 
Gelation is due to the bridging of adjacent cells into a network via polymer chains. The 
addition of α-CD reverses the gelation, as shown on the right (adapted from Dowling34). 
 
 
Our group has previously studied how hydrophbically modified chitosan (hm-
chitosan) interacts with vesicles and biological cells, both of which are covered by lipid 
bilayers.34-36  This interaction results in the formation of a gel, as shown in Figure 2.7. 
The driving force is the hydrophobic interaction between the hydrophobes on the polymer 
and the bilayers of cells/vesicles. Due to such interactions, polymers bind to cells, and 
this results in the cells being bridged by polymer chains into a 3-D network. Furthermore, 
this gelation was found to be reversible through addition of α-CD. The hypothesis is that 
α-CD molecules form inclusion complexes with the hydrophobes on hm-chitosan, 





2.1.4. Alginate Hydrogel Dissolution via Chelators   
As mentioned previously, alginate can be easily cross-linked into a gel using 
multivalent cations (e.g. Ca2+, Sr2+, Cu2+)  that form “eggbox” junctions between adjacent 
alginate chains. Conversely, the removal of these cations from the the junctions leads to 
degradation or dissolution of the alginate hydrogel. Many chemical chelators (e.g. 
EDTA) can strongly bind to cations and thus can induce gel dissolution.37 The binding is 
commonly represented through a stability constant,38 which is defined as below: 
 
where [M] is the concentration of the (metal) cation, [C] is the concentration of chelator, 
and [MC] is the concentration of the metal-chelator complex. Stability constants are 
equilibrium constants (expressed as a logarithm) of the above chelator-metal binding. 
Higher stability constants indicate strong chelation. Stability constants for commonly 
used chelators for divalent cations are summarized in Table 2.1. Note that gluconate ions 
have a high stability constant with copper (Cu2+) ions. We will explore the use of 
gluconate ions to remove Cu2+ crosslinks from an alginate bead in Chapter 5. 
 
 




2.3. OPTICAL MICROSCOPY 
2.3.1.  Brightfield and Phase Contrast Microscopy 
For the microparticles described in this dissertation, visual observations through 
brightfield microscopy offer a simple means to characterize them. In brightfield 
microscopy, objects are visualized through intensity differences between the specimen 
and the surroundings. For instance, when observing a polymer microparticle that is 
opaque or translucent, much of the light that is directly hitting the particle is absorbed, 
resulting in reduced intensity, whereas the light that does not hit the particle remains at 
the original intensity.40 This contrast allows real-time visualization of changes in 
microparticle morophologies (e.g. clustering, degradation). Overall, brightfield 
microscopy can be used to image objects that are larger than the wave length of visible 
light (400-700 nm).  
 
When imaging a transparent microparticle, the contrast, i.e., the intensity 
difference between the absorbed and surrounding light is reduced. However, through the 
use of phase-rings, one can modify conventional absorbtion-based brightfield techniques 
to provide greater contrast.40 Phase contrast takes advantage of the relationship between 
diffracted light from the specimen and the undiffracted background light. Diffraction of 
light by the specimen causes a phase shift—the light passing through the specimen slows 
down (≈ ¼ of a wavelength) due to the difference in refractive index between the 
specimen and surrounding air (Figure 2.8). Alternatively, the surrounding light that 
passes through with no diffraction remains in phase (S wave) and meets the diffracted 




resultant particle wave (P wave), which determines the contrast with which we see the 
specimen.40 Maximizing this destructive interference generates the most contrast between 
the sample and the surroundings. Thus, the ratio of the amplitudes of the S and D waves 
are the most important variables for enhancing contrast. Since only a small fraction of 
incident waves are diffracted by typical objects, in traditional brightfield microscopy, the 
destructive interference from diffraction is hardly noticable with the human eye. Thus, 
phase rings are used to absorb more surrounding S waves (reducing the overall amplitude 
of the S waves) and advance the S waves out of phase to the point of maximum 
destructive interference with the D waves (Figure 2.9).  
 
 
Figure 2.8. Phase relations between S, D and P waves in brightfield microscopy. The D 
wave is slowed by ¼ of a wavelength relative to the S wave, upon diffracting at the 
object, causing minimal destructive interference with the S wave to generate the resultant 






Figure 2.9. Phase relations between S, D and P waves in phase contrast microscopy. The 
S and D wave have maximized destructive interference to generate a resultant P wave 
that allows for greater contrast in the image (adapted from Murphy40). 
 
 
2.3.2. Fluorescence Microscopy 
Fluorescence microscopy allows for easy visualization of fluorescently labeled 
objects, which stand out in high contrast compared to the untagged surrounding 
environment. Throughout this dissertation, various elements of our microsystems are 
tagged with fluorescent markers to enable their tracking via fluorescence microscopy. 
Unlike brighfield microscopy, which relies on transmitted light, fluroescence microscopy 
relies on reflected light.40 Sharp contrast between the specimen and environment is 
achieved through the use of exictation and emission filters to allow for specific detection 
of only the fluorescently labeled specimen. As shown in Figure 2.10, the basic 
components of a fluorescence microscope comprise a light source, excitation and 
emission filters, dichroic mirror, and a detector. The source light is first passed through 




fluorescently labeled sample, upon excitation, then emits fluroescence at a lower 
frequency (i.e. higher wavelength) that passes through the dichroic mirror and emission 
filter to be collected by the detector.40  
 







MICROPARTICLES FOR CAPTURE OF RARE CELLS 
FROM BLOOD* 
 
*The results presented in this Chapter have been published in the following journal 
article: Chandamany Arya, Jason G. Kralj, Kunqiang Jiang, Matthew S. Munson, Thomas 
P. Forbes, Don L. DeVoe, Srinivasa R. Raghavan, and Samuel P. Forry, “Capturing Rare 
Cells from Blood Using a Packed Bed of Custom Synthesized Chitosan Microparticles.” 
Journal of Materials Chemistry B, 1, 4313-4319 (2013). 
 
3.1. INTRODUCTION  
The surfaces of many biological cells are designed to selectively adhere to 
specific objects within their environment. For example, leuokocytes within the immune 
system can adhere to various micron-sized objects such as foreign cells (pathogens) or 
even to other leukocytes and endothelial cells.17,41,42 Cellular adhesion relies on an array 
of specific biochemical interactions between the surface of one object and another. This 
ability of surfaces to recognize and bind to specific counterparts is also at the core of 
many diagnostic devices and assays. In this study, we apply the same surface-recognition 
concepts for the synthesis of functionalized microbeads, and we then adapt these 
microbeads for a diagnostic application.  
 
Over the past decade, there has been much interest in the isolation of rare cells 
such as circulating tumor cells (CTCs) or stem cells from whole human blood. Rare cell 
isolation remains a technical challenge because these cells are present in low numbers 
relative to red and white blood cells.3,43,44 For example, hematopoietic stem cells are 




cancer, just 1 per 109 blood cells are estimated to be CTCs.  Isolation of these rare cells is 
thereby especially challenging as large quantities of other cells must sorted and removed 
to provide sufficient purity of CTCs. Due to low throughput, conventional techniques for 
cell purification using fluorescence-activated cell sorting (FACS) are limited in CTC 
isolation.45 A wide variety of other approaches to capture CTCs from whole blood have 
been used. Some groups have used size-based techniques for isolation of CTCs,46 which 
are usually larger than leukocytes; however, CTCs originating from different tissue (i.e. 
different types of cancer) have varying size distributions.47 Other groups have used 
buoyancy and density based methods for CTC isolation.48,49 However, these methods are 
typically insufficient in isolation purity.45 Other methods for isolation involve targeting 
distinguished CTC surface markers using antibodies. Most commonly, these antibodies 
target the surface marker EpCAM (epithelial cell adhesion molecule), which is highly 
expressed on many epithelial cancer cells and thereby CTCs.50 It should be noted that 
although EpCAM is the most commonly used marker to capture CTCs, expression levels 
of EpCAM can vary based on the type of cancer. For instance, high expression of 
EpCAM is found in 95% of colon cancers, and only in 40% of breast cancers.50 The only 
current FDA-approved CTC detection technique (CellSearchTM) involves targeting 
EpCAM; the technique relies on bulk mixing of whole blood with paramagnetic anti-
EpCAM coated nanoparticles.43  
 
Compared to this bulk-mixing technique, microfluidic methods promise to 
substantially increase the capture efficiency due to their higher surface-to-volume 




antibody-coated posts to further enhance the contacts between cells and antibodies.3 
However, such devices are expensive and difficult to construct, especially for researchers 
who do not have specialized training in microfabrication techniques.  
 
Recently, a new design was introduced in collaboration with Dr. Forry’s group at 
NIST wherein near-monodisperse polystyrene beads (diameter ≈ 150 m) were packed 
into a bed within a microchannel containing a weir.52 The beads were commercially 
available with a surface functionality comprising the linker protein avidin. Pre-stained 
EpCAM expressing breast cancer cells were spiked into whole blood as a model CTC 
sample. After the addition of anti-EpCAM antibodies that were conjugated with biotin, 
this blood was pumped through the packed bed of avidin coated polystyrene microbeads. 
Cells labeled with the biotinylated anti-EpCAM became bound to the beads through 
biotin-avidin interactions and were enumerated through fluorescence microscopy.  
 
In this Chapter, we describe a similar device where, instead of commercial 
polystyrene beads, we develop custom-manufactured microbeads of the biopolymer, 
chitosan. Chitosan is derived from the deacetylation of chitin, a polysaccharide found in 
the exoskeleton of crustaceans and insects.53 It is inexpensive and abundant (chitin is the 
world’s second most common biopolymer),54 commercially available, water soluble 
below pH 6, and easily functionalized through its primary amine groups that allow 
covalent attachment of enzymes, antibodies, and DNA.54 The chitosan microparticles are 
created in-house using a microfluidic tubing device, with two-phase flow being used to 




device allows uniform particles to be prepared continuously in a single step at a 
throughput of about 5000 particles/h. No training in microfabrication techniques is 
necessary for preparing the particles. The microbeads are then functionalized by reaction 
with the primary amines along the chitosan backbone, allowing covalent attachment of 
the protein streptavidin. The core of the microbeads can also be put to use by 
encapsulating moieties of interest in it such as magnetic nanoparticles, fluorescent 
markers or other optical stains. Here, we encapsulate carbon black within the microbeads 
as a means to attenuate their auto-fluorescence. The final functionalized chitosan 
microbeads are packed into a bed and used to capture cancer cells spiked into whole 
blood at physiologically relevant densities. Captured cells are enumerated using 
fluorescence microscopy. Overall, the microbeads used here are low-cost and versatile, 
and their use within a microfluidic packed bed could prove to be a viable approach for 
capturing CTCs or other rare cells.  
 
3.2 EXPERIMENTAL SECTION 
Materials and Chemicals. Chitosan (medium molecular weight; degree of deacetylation 
≈ 80 %), the nonionic detergent SPAN80, nonpolar solvent hexadecane, the reducing 
agent sodium cyano-borohydride, the cross linking reagent glutaraldehyde (grade 1, 
70 %), 1-decanol, phosphate buffer saline (PBS, P4417), Albumin from bovine serum 
(BSA), and streptavidin (from Streptomyces Avidinii) were obtained from Sigma-Aldrich. 
Ethyl Alcohol was obtained from Pharmco-AAPER (180 Proof). Carbon black (N110) 
was obtained from Sid Richardson Carbon Company, fluorescent biotin (Atto 590-Biotin) 




were purchased from Spherotech ((6-8) μm), biotinylated anti-EpCAM was purchased 
from AbCAM (ab79079), and DiI, the fluorescent cell stain, was purchased from Life 
Technologies (V-22885).  
 
Tubing Device Design. Two-phase flow was generated in a microtubing device. Oil and 
aqueous chitosan solutions were loaded in plastic syringes (BD part # 301030) and 
pumped through an annular junction as shown in Figure 3.1.  The aqueous solution was 
pumped (1.5 L/min) through silica capillary tubing (i.d. 150 μm, o.d. 260 μm; SGE 
Analytical Science), inserted inside PTFE microtubing (i.d. 300 μm; Cole Parmer), which 
carried the immiscible oil phase (30 L/min).  Fluidic connections to the silica capillary 
and PTFE microtubing were made using five-minute epoxy (Devcon) and Luer-lock 
fittings (1/16” hose barb; Cole Parmer).  The rate of aqueous shearing and droplet 
formation depended on the oil and aqueous phase flow rates and was controlled using two 
independent syringe pumps (New Era Pump Systems Inc.; part # NE-300).   
 
Chitosan Microbead Synthesis. Two-phase flow was generated by a continuous oil 
phase (2 % by weight SPAN80 in hexadecane) and a dispersed aqueous phase (2 % by 
weight chitosan in DI water); flow rates used for the aqueous phase and continuous phase 
were 1.5 L/min and 30 L/min, respectively. For generation of carbon black 
encapsulated chitosan microbeads, the chitosan solution was mixed with 1 % by weight 
carbon black, prior to injection into the syringe. The droplets generated from the tubing 
device were collected in a cross-linking solution (2 % by weight glutaraldehyde, 2 % by 




over 20 h to generate over 105 chitosan microparticles. The microparticles were left to 
incubate in the cross-linking solution overnight. They were then washed, by allowing the 
beads to settle to the bottom of the solution and replacing the existing solution, in a series 
of solvent exchange steps: pure hexadecane (5 times), 1-decanol (5 times), ethanol (5 
times) and PBS (5 times). After washing, the chitosan microparticles did not aggregate 
and they also retained their original monodispersity; however, their size shrank by ≈ 
40 % through cross-linking and solvent exchange. The final diameters of the chitosan 
microbeads were measured using brightfield transmission microscopy images. The 
images were analyzed in MATLAB, using a Hough Transformation to measure their 
projected diameter.62  This approach is susceptible to error in determining the absolute 
particle size (due primarily to accurate edge determination), but provides a good 
assessment of size heterogeneity between particles.  The measured sizes from individual 
microparticles (n=91) were then arranged as a histogram (bin size = 6.5 μm) in Figure 3.2 
along with a Gaussian fit to the data. 
 
Functionalization of Chitosan Microbeads. Chitosan microbeads in PBS were exposed 
to glutaraldehyde (8 % by weight, 2 h) and washed in PBS (3 times). The microparticles 
were then exposed to either BSA or streptavidin (100 μg/mL in PBS) overnight at 4 °C, 
and sodium cyano-borohydride (1 % by weight, 30 minutes) was added to fix the binding 
between the chitosan microparticles and streptavidin.63 Finally the chitosan microbeads 
were washed in PBS (7 times). Fluorescent intensity was measured on an inverted 
fluorescent microscope (Axio Observer, DI, Zeiss; 60× magnification, using a TRITC 




samples containing 0 % by weight and 1 % by weight carbon black as outlined in Figure 
3.3. Functionalization of the streptavidin was tested using fluorescently labeled biotin.  
The streptavidin functionalized beads were incubated in a working concentration of 4 
μg/mL Atto-590 biotin, overnight at 4 °C.  The beads were washed in PBS (7×) and then 
the fluorescent intensity was measured using the TRITC filter set. Functionalization at 
the bead surface was verified by mixing the streptavidin functionalized chitosan 
microbeads with biotinylated polystyrene microspheres (500 000 beads/mL) on a rotary 
shaker (90 RPM, 30 min).  Similarly, human breast cancer cells (MCF-7, cultured as 
described previously52) were functionalized by incubation with biotinylated anti-EpCAM 
(0.2 μg/mL) for 30 minutes, and the cells were washed in PBS (3×). Binding of 
biotinylated cells to streptavidin-functionalized chitosan microbeads was tested (Figure 
3.7) by mixing the MCF-7 cells (100 000 cells in 1 mL PBS) with the chitosan 
microbeads on a rotary shaker (90 RPM, 30 minutes). 
 
Rare Cell Capture Device and Experiments. Streptavidin functionalized chitosan 
microbeads that encapsulated carbon black were used for the rare cell capture in a 
microfluidic device. The experiments testing for rare cell capture in a PDMS microfluidic 
device were similar to previous work52, except chitosan microbeads were used instead of 
polystyrene particles. MCF-7 cells were stained with a membrane dye (DiI, Life 
Technologies), following the manufactures recommendations, and spiked into whole 
human blood at known densities to mimic clinical CTC samples. Biotinylated anti-
EpCAM (0.2 μg/mL) was then added to the blood sample, directly labeling the EpCAM 




bed. The whole blood samples were then pumped through the microfluidic packed bed. 
Immobilized MCF-7 cells within the microfluidic packed bed were washed with 200 µL 
PBS and then identified by fluorescent intensity in ImageJ.64 
 
3.3. RESULTS AND DISCUSSION 




Figure 3.1. Photographs and schematic of the tubing device used to generate chitosan 
microbeads. The device (a) is formed by inserting capillary microtubing into slightly 
larger PTFE tubing. A close-up of the device is shown in (b) and a schematic at the 
junction between the two phases is shown in (c). An aqueous chitosan solution is pumped 
through the inner tubing. Oil pumped through the outer tubing exerts shear on the 
aqueous phase at the annular junction, causing uniform microdroplets containing chitosan 
to break away and flow down the tubing. These microdroplets are collected and cross-





We used a co-flow tubing device made with commercially available tubing 
(Figure 3.1a) to synthesize the chitosan microbeads. Others have reported using similar 
devices to generate droplets.65,66 This device allowed a stream of oil (hexadecane) in the 
annulus region to contact an aqueous stream containing dissolved chitosan in the inner 
tube. The oil flow sheared the aqueous chitosan solution into uniform spherical droplets 
(Figure 3.1b). The droplet size correlated with the inner diameter of the outer tubing and 
therefore the size could be varied by appropriate selection of the tubing. Using the tubing 
device, regular chitosan droplets were formed continuously at a rate of ≈ 5000 per hour.  
 
Chitosan droplets were converted to microbeads using glutaraldehyde as the 
cross-linker similarly to previous microfluidic studies, where chitosan microbeads were 
manufactured using microfluidic T-junctions.30 Using the co-flow tubing device, the 
aqueous chitosan droplets were collected in a solution of glutaraldehyde in hexadecane 
and were left to cross-link for ≥ 20 h. We typically synthesized batches of about 105 
discrete beads. The beads were transferred from the hexadecane phase to an aqueous 
buffer (phosphate-buffered saline, PBS) by a series of solvent exchange washing steps. In 
PBS, the beads remained stably dispersed (i.e. no aggregation) for over 2 years. Figure 
3.2a shows a bright-field optical micrograph of the beads. The size distribution 
determined from these micrographs (Figure 3.2b) shows that the microbeads have a 
narrow size distribution (4.3% RSD). Thus, our method yields near-monodisperse 








Figure 3.2. Particle Sizing. Optical micrographs of chitosan microbeads (a) showed that 
the microbeads were uniform and nearly monodisperse. The mean particle diameter (b) 
was ≈ 164 µm with a relative standard deviation of 4.3% (n = 91). The solid line in (b) is 
a Gaussian fit to the data.        
    
 
3.3.2. Functionalization of Chitosan Microbeads 
 Chitosan microbeads cross-linked with glutaraldehyde exhibit an intrinsic 
autofluorescence across multiple wavelengths (Figure 3.3a,b), as has been noted 
before.67-68 Here, the autofluorescence is not a desirable feature since it could interfere 
with the enumeration of cells by fluorescence microscopy.69 Others have shown carbon 
black, a nanoparticle pigment, as a fluorescence quencher.70 To attenuate the 
autofluorescence in the chitosan microbeads, we encapsulated nanoparticles of carbon 
black (nominal size 12 nm). For this, 1 % by weight of carbon black was dispersed in the 
aqueous chitosan solution used in the tubing device. Chitosan droplets bearing carbon 
black were cross-linked by glutaraldehyde as before. The resulting microparticles 
containing carbon black (Figure 3.3c,d) were almost completely opaque and showed a 
50-fold reduction in detectable autofluorescence across multiple wavelengths. This 
enabled fluorescent cell detection without interference from the native chitosan 




                  
Figure 3.3. Chitosan encapsulation of carbon black nanoparticles. Bare chitosan 
microbeads cross-linked by glutaraldehyde (a, b) were transparent and exhibited an 
intrinsic autofluorescence. By encapsulating 1 % by weight carbon black (c, d), the 
microbeads were rendered opaque, and autofluorescence was reduced 50-fold. (Image 
contrast is identical for (b) and (d).)   
   
 
 
Figure 3.4. Fluorescent image of DiI-stained cells and chitosan microbeads (diameter ≈ 
164 µm). The chitosan microbeads were loaded with 1% by weight carbon black to 
attenuate their intrinsic autofluorescence. The one bright microbead contained no carbon 
black and emitted a strong autofluorescence that was much brighter than the microbeads 
encapsulating carbon black or fluorescently stained cells. This image was taken using an 
inverted fluorescent microscope and a TRITC filter set (Ex: 520-570; Em: 535-675) at 




Next, we functionalized the chitosan microbeads with the protein streptavidin. 
Others have reported covalently anchoring proteins to thin films of chitosan71, using 
glutaraldehyde to attach the chitosan amines to primary amines on proteins. Since 
glutaraldehyde was already used here to cross-link the chitosan microbeads, additional 
glutaraldehyde was added (to completely saturate free amine groups with aldehydes 
linkages).  Subsequent addition of a streptavidin solution yielded streptavidin covalently 
anchored to the chitosan backbone. This was verified by incubating the particles with 
fluorescently tagged biotin, followed by washing to remove unbound moieties. A 
significant increase in fluorescence intensity was observed (Figure 3.5), indicating the 
binding of biotin to covalently attached streptavidin throughout the microbead volume.  
 
Figure 3.5. Fluorescent biotin increased the fluorescent intensity of streptavidin-
functionalized chitosan microbeads. The chitosan microbeads, which encapsulated 1% by 
weight carbon black, were covalently functionalized with streptavidin.  Following 
exposure to fluorescent biotin in solution followed by washing, a significant increase in 
fluorescent intensity was observed. These images were taken using an inverted 







For the application of rare cell capture, we were particularly interested in 
streptavidin functionalization at the microbead surface.  This was tested using micron 
sized biotinylated spheres; the polystyrene based biotinylated microspheres were too 
large ((6-8) m diameter) to diffuse into the chitosan microbead, but exhibited significant 





Figure 3.6. Attachment of small biotinylated polystyrene spheres (6-8 μm) to 
streptavidin-functionalized chitosan microbeads. When chitosan microbeads were mixed 
with the commercially available biotinylated polystyrene spheres, significant surface 
attachment of the spheres to the chitosan microbead demonstrated that covalently bound 








Finally, as a prelude to our rare cell capture experiments, we studied the binding 
of MCF-7 breast cancer cells to chitosan microbeads in free solution (Figure 3.7). The 
cells were first combined with a biotinylated antibody to EpCAM, which is a ligand that 
is highly expressed by MCF-7 cells. Cell binding was studied with BSA-functionalized 
microbeads (control experiment) as well as streptavidin-functionalized microbeads 
(Figure 3.7). (Note that, for these studies, microbeads without carbon black were chosen 
so as to facilitate visualization in bright-field images.) In the case of the BSA-
functionalized microbeads, little or no binding of biotinylated MCF-7 cells was seen 
(Figure 3.7a). Conversely, the MCF-7 cells substantially cover the surfaces of the 
streptavidin-functionalized microbeads (Figure 3.7b). These studies show that 
functionalized chitosan microbeads can specifically target biotinylated cells.      
 
 
Figure 3.7. Specificity of cell-binding to chitosan microbeads. Chitosan microbeads 
functionalized with BSA (a) exhibit no specific interaction with biotin covered MCF-7 
cells (the MCF-7 cells were treated with biotinylated anti-EpCAM against highly 
expressed surface proteins). However, streptavidin-functionalized chitosan microbeads (b) 





3.3.3. Rare Cell Capture with Chitosan Microbeads 
 The microfluidic chip design for rare cell capture was identical to the studies done 
in collaboration with Dr. Forry.52 The Polydimethylsiloxane (PDMS) glass slide 
microfluidic chip consisted of a simplistic design containing 5 parallel capture channels 
(170 μm tall, 2 mm wide, 45 mm long) with a shallow weir that was 120 μm tall, 2 mm 
wide and 1 mm long as shown in Figure 3.8. Streptavidin-functionalized chitosan 
microbeads were loaded into a microfluidic channel in such a way that the microparticles 





Figure 3.8. Image of the packed bed microfluidic capture device.52  Top and side view of 
the chip shows that the beads are packed against a shallow weir (a,b).   
 
 
A model sample to mimic CTCs in blood was prepared using MCF-7 breast 
cancer cells labeled with a fluorescent membrane stain. These cells were spiked into 
whole blood at clinically relevant densities ((0-1000) cells per mL of blood). This sample 
was then exposed to a biotinylated anti-EpCAM antibody to specifically tag the MCF-7 
cells with biotins. Thereafter, the whole blood sample was pumped through the 
microfluidic packed bed at a flow rate of 0.2 mL/h. Figure 3.9b shows a closer 




noted earlier, the autofluorescence of the chitosan microbeads has been sufficiently 
attenuated so that the captured fluorescently labeled cells show up as bright spots in the 
image, which allowed the cells to be counted easily in ImageJ.64  When the total number 
of captured cells observed throughout the packed bed was plotted against the number of 
cells spiked into blood samples, a linear correlation was observed (Figure 3.9c). The ratio 
of these quantities represents the overall capture efficiency ≈ 31 %.  
 
 
Figure 3.9. Capture of cancer cells from whole blood. The streptavidin functionalized 
chitosan microbeads were loaded into a microfluidic channel.  The uniform size of the 
microparticles led to the generation of a uniform packed bed (a).  After pumping through 
model CTC blood samples (200 μL), captured cancer cells were imaged by fluorescence 
microscopy (b; expanded view of the rectangle in (a)). The total number of cancer cells 
captured and enumerated in the packed bed exhibited a linear response across the 
physiologically relevant range (c).  A linear regression and Working-Hotelling 95% 






For comparison, the earlier packed bed based on polystyrene beads gave similar 
variability between different blood donors and a capture efficiency of about 40 %.52 We 
speculate that some of the cells captured by the chitosan-based packed bed could not be 
counted because of the opacity of the carbon black in the microbeads – i.e., if the cells 
were captured on the far side of the microbeads. Overall, these results are promising and 
demonstrate the utility of functionalized chitosan microbeads for rare cell capture. Our 
calculations show that a single batch of 105 chitosan microbeads prepared using our 
tubing device is sufficient to fill over 50 packed beds like the one shown in Figure 3.9. 
This process was not fully optimized, but based on the costs of the materials (not 
including labor), this translates to a cost of ≈ $1.50 per packed bed of chitosan 
microbeads; for comparison, a similar packed bed of commercially available streptavidin-
coated polystyrene beads costs ≈ $25. In addition to lower cost, the chitosan microbeads 
offer key advantages in versatility since both their inner contents as well as their outer 
surfaces can be tailored very easily.      
 
3.4. CONCLUSIONS 
We have shown development of monodisperse chitosan microbeads that can 
selectively recognize and adhere to specific types of biological cells. To do so, we have 
utilized a simple device based on inexpensive and commercially available microtubing 
for bulk generation of uniform chitosan microbeads. Microbead properties were 
modulated through both physical encapsulation and covalent chemistry: inclusion of 
carbon black provided a means to attenuate the intrinsic autofluorescence of the 




linked microbeads, thereby allowing the particles to bind to any biotinylated antibody. 
For applications in potential diagnostics, we have adapted use of the custom-
functionalized chitosan microbeads into a microfluidic platform. The uniform chitosan 
microbeads were loaded into a microfluidic packed bed for proof-of-concept studies in 
rare cell capture. Using this packed bed, model cancer cells (MCF-7) were captured from 
whole blood at physiologically relevant levels. In comparison to the commercial 
polystyrene microparticles used previously, chitosan microbeads were an order of 
magnitude cheaper and could offer unique advantages as a tunable biopolymer-based 
material. The versatility of custom synthesized chitosan microbeads allows for generation 
of more advanced capture devices. For example, alternate capture antibodies could allow 
isolation of other types of rare cells such as hematopoietic stem cells (HSCs)72, and the 
incorporation of magnetic nanoparticles could allow magnetic manipulation of the 
chitosan microbeads. Our overall approach should be attractive to researchers interested 
in customized in-house cell isolation and DNA capture studies through the simplest, 

















4.1. INTRODUCTION  
Microparticles have found relevance in a variety of fields ranging from drug 
delivery73 to environmental science74 to biosensing.75 Microfluidic methods have become 
popular as a means to generate microparticles of controlled size,61 morphology,76 and 
functional properties.77 Moreover, methods have been developed to assemble individual 
microparticles into larger structures78 including chains,30,79 rings,80 and various cubic and 
hexagonal three-dimensional lattices.81 Also, clustering or agglutination of microparticles 
into larger aggregates serves as the basis for several assays, including for the detection of 
pathogens.82  
 
Much of the interest in studying aggregation of microparticles in response to 
stimuli stems from the existence of similar processes in nature. For example, in the 
cytoskeleton of cells, individual subunits of globular actin (G-actin) self-assemble into 
long semi-flexible filaments (F-actin).83 Another example is the clotting cascade that is 
initiated in response to bleeding. Here, the particles involved are the blood platelets, and  
the net result of particle aggregation is the formation of a blood clot. Although blood 
clotting is a complex multi-step biochemical process, two physical processes can be 




reconfigured to allow binding with the water-soluble fibrinogen protein84 and (2) 
fibrinogen is polymerized into water-insoluble fibrin chains through activation of the 
enzyme thrombin. As these steps proceed, fibrin/fibrinogen chains stick to multiple 
platelets and thereby bridge the platelets into clusters that are called “platelet plugs”. 
Subsequently, the precipitated fibrin forms a mesh or web around the platelet plugs, and 
in the process this web also traps the surrounding red and white blood cells (RBCs and 
WBCs). The overall result is a blood clot.85 
 
In this Chapter, we will present a new way to generate clusters of microbeads 
through hydrophobic interactions accompanied by precipitation of a polymer on the 
surface of the beads. We use an associating biopolymer (i.e. a water soluble polymer 
bearing hydrophobic groups along the backbone) that can interact with our functionalized 
bead surface through hydrophobic interactions. The biopolymer is the polysaccharide, 
chitosan53 (which is positively charged at acidic pH); we attach n-dodecyl tails to the 
chitosan backbone to obtain hydrophobically-modified chitosan (hm-chitosan). Over the 
past few years, our group has studied hm-chitosan in conjunction with vesicles35,36 and 
biological cells.34 We have shown that hm-chitosan converts vesicle/cell suspensions into 
a gel via hydrophobic interactions. Moreover, this gelation can be reversed by adding 
α-cyclodextrin (α-CD), a sugar-based supramolecule with a hydrophobic binding 
pocket.85,86 The reversal occurs because the hydrophobes on hm-chitosan get sequestered 
within the binding pockets of α-CD molecules.34 Here, we exploit the same affinity 
between hm-chitosan and α-CD, but in the context of microparticles. That is, we 




then combined with hm-chitosan chains, thus facilitating specific binding interactions 
between the chains and the bead surfaces (Figure 4.1b). To our knowledge, the use of 
hydrophobic interactions to induce polymer-particle binding is new and distinct from 
previous antibody-antigen86,87 based approaches.  
 
 
Figure 4.1. Schematic illustrating proposed interactions of cyclodextrins on the surface 
of the bead with hm-chitosan. Commercially available sulphated -cyclodextrins 
(negatively charged) are mixed with positively charged beads to allow for surface coating 
of the microbeads with -cyclodextrins (a). hm-chitosan polymer interacts with the 
surface of the microbeads through hydrophobic interactions (b).    
 
A further distinctive feature of our study is that we are able to visualize clustering 




two-step process that is reminiscent of blood clot formation: that is, first, loose clusters of 
microbeads are formed, akin to “platelet plugs”. Subsequently, the polymer (hm-
chitosan) precipitates around these clusters and thereby fortifies these clusters. These 
hybrid clusters have sufficient density and integrity so that inert particles can get trapped 
within them, much like RBCs within a blood clot. This kind of particle clustering could 
have further applications in embolization,88 where biopolymer-based beads are used to 
clot and occlude blood flow to either prevent internal hemorrhaging or to prevent the 
growth of tumors.89    
 
4.2 EXPERIMENTAL SECTION 
Materials and Chemicals. Chitosan (medium molecular weight; degree of deacetylation 
≈ 80 %), the nonionic detergent SPAN80, nonpolar solvent hexadecane, the cross-linking 
reagent glutaraldehyde (grade 1, 70 %), 1-decanol, α-cyclodextrin sulfated sodium salt 
hydrate, sodium chloride (NaCl), and NHS-fluorescein (Fluorescein-5-EX N-
hydroxysuccinimide ester) were obtained from Sigma-Aldrich. Ethanol was obtained 
from Pharmco-AAPER (190 Proof). Red-fluorescent carboxylate-modified nanospheres 
(100 nm) were obtained from Life Technologies (F-8801). Carbon black (N110) was 
obtained from Sid Richardson Carbon Company. Magnetic iron (III) oxide, gamma-phase 
(γ-Fe2O3) nanoparticles (surface area ≈42 m
2 g−1) were purchased from Alfa Aesar.  
  
Chitosan Microbead Synthesis and Analysis. A two-phase co-flow microfluidic device, 
as shown by Arya et al.90, was used to generate chitosan droplets (2 wt%), which were 




chitosan solution was mixed with 1 wt% carbon black to generate carbon black 
encapsulated chitosan microparticles. Likewise, magnetic chitosan microspheres were 
generated by dispersing γ-Fe2O3 nanoparticles (0.5 wt%) into the chitosan solution, prior 
to cross-linking, as described in a previous study.30 Residual positive charge of 
crosslinked chitosan microbeads in acidic aqueous solutions was tested using red-
fluorescent carboxylate modified nanoparticles (100 nm). Chitosan microbeads 
(encapsulated with carbon black to attenuate auto-fluorescence) were mixed with 
fluorescent nanoparticles (1:200 dilution of stock in acetic acid water, pH 4.5) for 30 min, 
washed in pH 4.5 water (3 times), and observed under an inverted fluorescent microscope 
(Zeiss Axiovert 135, 20× magnification) using Zeiss Filter set 15 (excitation BP 530-560 
nm; emission LP 590 nm). Relative fluorescent intensity was then measured and 
compared to chitosan beads that were not exposed to the fluorescent nanoparticles and 
also to chitosan beads that were exposed to fluorescent nanoparticles in presence of salt 
(NaCl; 2 M) to demonstrate that electrostatic interactions were indeed responsible for 
nanoparticle interaction with the microbeads. 
 
Cyclodextrin Coating and Clustering Experiments with Chitosan Microbeads. 
Chitosan microbeads in DI water containing acetic acid (pH=4.5) were exposed to 
sulfated α-cyclodextrin (5 wt%) for an hour under gentle mixing, then washed five times 
with acidic water (pH=4.5). The beads were maintained in acidic water solution prior to 
use in the clustering experiments. The hm-chitosan used in this study was synthesized as 
described in previous work.16 Fluorescently labeled hm-chitosan was prepared following 




unmodified chitosan. For microbead clustering studies, hm-chitosan was dissolved (0.1 
wt%) in aqueous salt solution (0.9 wt% NaCl). Chitosan beads (≈ 200) functionalized 
with α-CD were placed on a slide glass in 25 μL of solution (acidic water) and 25 μL of 
hm-chitosan solution was added. A micropipette tip was used to gently mix the sample. 
The results were observed under brightfield microscopy (Zeiss Axiovert 135; 10x 
magnification).  
 
4.3. RESULTS AND DISCUSSION 
We used a simple process for functionalizing chitosan microbeads with 
cyclodextrins.92 The starting materials are the chitosan microbeads produced by our 
microfluidic method. These beads are nearly monodisperse with a diameter of 164 µm 
(same as those used in Chapter 3). Note that the beads are formed by crosslinking 
chitosan using glutaraldehyde. Since chitosan is a cationic polymer, the beads retain 
significant residual positive charge on their surface. As a result, anionic molecules or 
particles can be bound to the bead surface by electrostatic interactions.  
 
To show this, we first exposed the chitosan microbeads to anionic (carboxylate-
functionalized) nanoparticles (100 nm diameter) that are labeled with a red fluorescent 
dye. After exposure for 30 min, the beads were washed extensively and then observed 
under a fluorescence microscope (Figure 4.2). We find substantially higher fluorescence 
for these beads (Figure 4.2b) relative to the bare beads (Figure 4.2a) (the fluorescence is 
about 3 times higher for the former). This indicates the binding of anionic nanoparticles 




enough such that the nanoparticles are not removed from the bead surface even after 
extensive washing of the beads. Also, the nanoparticle-bead binding is much less if the 
two were incubated in the presence of salt (2 M NaCl), as shown by Figure 4.2c. Salt is 
known to screen and thereby diminish the attractive electrostatic interactions between 
charged species. Thus, the results from Figure 4.2 confirm that electrostatic interactions 
are sufficient to ensure the stable binding of nanoparticles to bead surfaces.  
 
 
Figure 4.2. Comparison of relative fluorescent intensity of chitosan microbeads after 
exposure to anionic fluorescent nanoparticles. Typical images are shown of: (a) Bare 
chitosan bead (control); (b) Bead after incubation with nanoparticles, followed by 
extensive washing. The higher fluorescence shows the strong binding of the nanoparticles 
to the bead surface; (c) Bead after incubation with nanoparticles in the presence of salt 
(NaCl; 2M), followed by washing. The lack of fluorescence in this case indicates 
negligible binding of the nanoparticles. Scale bars: 100 µm. 
 
 Based on the above results, we proceeded to functionalize chitosan microbeads 
with cyclodextrins. For this, an anionic form of α-CD, i.e., sulfated α-CD was used 
(Figure 4.1a). The sulfated α-CD (5 wt%) was combined with the chitosan microbeads 
(1000 beads/mL) for a period of 1 h. Note that the concentration of sulfated α-CD is in 
large excess of that needed for saturating the surface of the beads. Following this step, the 
beads were washed 3 times and then stored in aqueous solution, where they remain stable 




stable with time, at least over a period of a week. That is, both freshly prepared beads as 
well as beads stored for a week give identical results.      
 
 
Figure 4.3. Optical microscopy images showing clustering of cyclodextrin coated 
microbeads (≈ 165 µm) upon mixing with hm-chitosan. Microbeads, which are covered 
with cyclodextrins, are mixed on a slide glass with hm-chitosan solution and microbead 
clustering is observed within a minute after exposure. Scale bars: 1 mm. 
 
We then proceeded to study the effect of adding hm-chitosan to the CD-
functionalized beads. The experiments were done under the optical microscope to allow 
changes to be observed in real time. A dilute (0.1 wt%) solution of hm-chitosan was 
added to the beads at time t = 0. Note that the beads are initially discrete and 
unaggregated (Figure 4.3a). Within a minute of hm-chitosan addition, we found that large 
clusters of the microbeads were formed (Figure 4.3b). Importantly, hm-chitosan was an 
essential trigger for this clustering; no clustering of the microbeads was observed using 
the same concentration of native (unmodified) chitosan. Moreover, surface coating with 
CDs was also essential for the clustering; microbeads that did not have the CDs did not 




observations suggest that interactions between the hydrophobes on hm-chitosan and the 




Figure 4.4. Optical microscopy images showing growth over time of a visible hm-
chitosan precipitation around the microbead clusters after initial cluster formation. Scale 
bars: 200 µm. 
 
  
Further interesting changes were observed in the hm-chitosan + CD-microbead 
system as time progressed (Figure 4.4). As mentioned, the initial clustering of 
microbeads occurs rapidly (within t = 1 min, see Figure 4.4a). Subsequently, we observed 
the growth of a precipitate around the microbead clusters over the course of t = 12 min 
(Figure 4.4b and c). Note that the precipitate is like a porous mesh and it coats all the 
particles in the cluster. At the same time, the precipitate does not nucleate from the 
surrounding bulk solution. This precipitate is most likely the hm-chitosan chains falling 
out of solution, evidently due to strong interactions with the CDs on the bead surface. 
This is also supported by observations of individual CD-coated microbeads immersed in 
an hm-chitosan solution (Figure 4.5a). We further verified the identity of the precipitation 
by labeling hm-chitosan with a green fluorescent dye and combining it with the CD-
coated beads. It can be noted from Figure 4.5c, that the precipitate around the cluster 





Figure 4.5. Optical microscopy images showing polymer precipitation around individual 
and small groups of microbeads. An individual cyclodextrin coated microbead is 
observed with precipitation around the bead surface upon hm-chitosan stimulation (a). 
Pair of cyclodextrin coated microbeads are held together in hm-chitosan precipitated web 
(b). Fluorescent labelled hm-chitosan is used to confirm that the precipitated web on the 
surface of the beads is hm-chitosan (c). For Image (c), brightfield and fluorescent 
microscopy image were taken and overlaid. Note: carbon black was encapsulated for 
visualization and to reduce autofluorescence (b, c). 
 
This was further verified by mixing dissolved hm-chitosan (0.1 wt%) solution 
directly with sulfated -CDs (5 wt%) as shown in Figure 4.6a. The initially soluble hm-
chitosan precipitates out of solution upon strong interactions with sulfated -CDs. By 
pre-coating the surface of the chitosan microbeads with sulfated CDs, we can ensure that 
the hm-chitosan precipitation nucleates from the bead surface to generate these unique 
types of microbead clusters as shown in Figure 4.5. Alternatively, if the chitosan beads 
were not pre-coated with sulfated -CDs, and instead simultaneously mixed with sulfated 
-CDs and hm-chitosan, precipitation was observed to nucleate within the solution and 
not directly around chitosan microbeads (Figure 4.6b). Importantly, the growth of the 
polymer web on the surface of the beads was only seen on beads that were previously 
coated with cyclodextrins. To show this point, we prepared two populations of beads, 






Figure 4.6. Visual and optical microscopy observations of hm-chitosan precipitation out 
of solution. Initially, hm-chitosan is dissolved in an aqueous solution; however, upon 
addition of sulfated -cyclodextrins, the hm-chitosan precipitates out of solution (a). 
When unmodified chitosan beads (not pre-exposed to sulfated cyclodextrins), were mixed 
simultaneously with dissolved hm-chitosan and sulfated -cyclodextrins solutions, the 
precipitation was observed to nucleate within the solution and not directly around the 
chitosan microbeads (b). Scale bars: 100 µm. 
 
One set of beads are the same transparent ones from Figure 4.3 with a diameter of 
165 µm and having CDs on their surfaces. The other set of beads contain carbon black 
and their diameter is 150 µm; these beads are opaque and black due to the carbon black, 
and they are also inert, i.e., there are no CDs on their surfaces. As seen in Figure 4.7, only 
the transparent CD-coated microbeads have a growth of a polymer precipitate around 
them (Figure 4.7b), while the inert black beads do not show a visible precipitate on their 
surface (Figure 4.7c). Interestingly, the inert beads either remained as individual entities 
(i.e., did not cluster) or they were trapped in the polymer web around the CD-coated 
beads (Figure 4.7d). This shows that the precipitated polymer web can trap surrounding 







Figure 4.7. Two sets of beads are mixed together and exposed to hm-chitosan. One of set 
of beads (transparent beads) are covered in cyclodextrins and the second set of beads 
(encapsulated with carbon black) do not have cyclodextrins on the surface (a). Upon 
exposure to hm-chitosan, the transparent beads generate a surrounding precipitated 
polymer web (b), while the inert carbon black beads do not generate their own polymer 
matrix; they either remain as independent beads (c), or they are trapped within the 
polymer web of the transparent beads (d). Scale bars: 200 µm.  
 
Our observations suggest an analogy between the above structures and the 
structures formed during blood clotting. As mentioned earlier, one of the first physical 
processes in the blood clotting cascade involves fibrinogen interaction with the surface 
receptors on platelets, which leads to formation of visible “platelet plugs” that act as a 
temporary barrier on the wound, until strengthened by the formation of the fibrin mesh. 
The initial clustering of CD-coated microbeads, driven by hydrophobe-CD interactions, is 
thus similar to the formation of a platelet plug. The growth of the hm-chitosan polymer 
web from the surfaces of the beads in this cluster is reminiscent of fibrin precipitating out 
of solution around the initial platelets plug to form the blood clot. Just as surrounding red 
blood cells, which are not active in the clotting cascade, are trapped in the fibrin polymer 
web, here also the inert beads are trapped in the polymer web that forms around the initial 




be useful in making artificial blood clots for embolization. This process commonly uses 
biopolymer beads of similar sizes to occlude blood vessels, either for the purpose of 
treating internal hemorrhage or to starve tumors of blood.88   
 
 
Figure 4.8. Images showing the entire bead-polymer matrix being moved with a magnet. 
The carbon black beads are completely inert (i.e. nonmagnetic and not covered in 
cyclodextrins) and they are trapped in the polymer matrix of the transparent beads 
(magnetic beads that are covered in cyclodextrins). The magnetic beads move the entire 
matrix, including the inert carbon black beads, from left to right. Scale bars: 200 µm.    
 
 
The trapping of inert objects within the polymer-bead cluster/mesh also suggests a 
means to deliver groups of micron-sized objects to a targeted location. To demonstrate 
this concept, we encapsulated magnetic nanoparticles in the transparent cyclodextrin CD-
coated beads from Figure 4.7. The inert black beads are non-magnetic and represent 
hypothetical cargo that needs to be moved towards a desired location. As before, the 
black beads are trapped in the polymer web generated around the CD-coated transparent 




together with the inert black beads that are trapped in it (Figure 4.8b, and c). Note that the 
uncaptured single black microbead below the cluster does not move and is unaffected by 
the magnet.  
 
4.4. CONCLUSIONS 
We have developed a class of microbeads that undergo clustering (aggregation) in 
the presence of specific polymers. The morphology of the clusters resembles those that 
occur during blood clotting. Our system consists of chitosan microbeads coated with 
CDs, which are then exposed to hm-chitosan, a polymer with hydrophobic pendant 
groups. Interactions between the hydrophobes on the polymer and the CDs on the 
microbeads are important to the clustering of the microbeads. Initial clusters mimic the 
temporary “platelet plugs” that form during clotting. Subsequently, the hm-chitosan 
precipitates out of solution and forms a matrix around the particle clusters. This is 
reminiscent of the conversion of soluble fibrinogen to an insoluble fibrin mesh around the 
platelet plugs in the case of a blood clot. The precipitated hm-chitosan matrix or web is 
able to entrap  “bystanders”, i.e., inert microbeads within it; this web is strong enough to 
transport the captured bystander beads to desired locations. Such microbead clustering 
could be useful in embolization, which is used to occlude blood vessels within the 






DEVELOPMENT OF “KILLER” MICROPARTICLES 
 
 
5.1. INTRODUCTION  
 The controlled release of cargo from polymer microbeads and microcapsules is of 
considerable interest, particularly in applications related to drug delivery.93,94 As carriers 
of a potentially valuable payload, these microparticles need to be carefully designed; they 
must both be robust enough to protect the payload from external threats and 
simultaneously be susceptible to breaking, when required, to release the payload at the 
appropriate time and location. Thus, many research groups have explored various routes 
towards triggered degradation of polymer microparticles, in response to stimuli such as 
biomolecules (e.g. enzymes), temperature, osmotic pressure, light, and pH.95,96  
 
Interestingly, nature has developed more sophisticated methods for targeted 
degradation of biological cells, which serves as a useful inspiration for triggered 
microparticle degradation. For example, consider biological cells in the body that are 
infected with pathogens like viruses. The immune system can both identify and eliminate 
these infected cells.97 Specifically, a subset of white blood cells, known as killer T cells, 
have the machinery for targeted degradation of infected cells. For example, T cells can 
generate and secrete cytotoxic proteins such as perforin and granzymes,98 (packaged 
within exosomes). The immune cells move towards the infected cells and locally release 




the process occurs only near the infected cells, properly functioning neighboring cells are 
not affected.99 The same killer T cell can then move on and use the same mechanism to 
eliminate infected cells in other regions of the body. 
 
 
Figure 5.1.  Schematic illustrating destruction of an infected cell in the body by a killer T 
cell. This is a simplified illustration of how a killer T cell attacks infected cells. Once the 
killer T cell is near the infected cell, it binds and delivers a “lethal burst” of cytotoxic 
proteins at the infected cell, resulting in apoptosis (programmed cell death) of the 
infected cell.99 
 
In this Chapter, we describe the development of particles that are inspired by the 
functions of immune cells. Specifically, our particles have the ability to selectively target 
certain kinds of surrounding particles for destruction. To accomplish this, we immobilize 
the enzyme glucose oxidase (GOx) in chitosan capsules, thus creating “killer” capsules. 
In the presence of glucose from the external environment, our killer capsules 
continuously generate gluconate ions, which are a known chelator of metal ions like 
copper (Cu2+). Thus, the killer capsule can target particles that are crosslinked by metal 
ions. Here, our targets are beads of alginate crosslinked by Cu2+. When the killer capsules 
and target beads are brought close to each other, the gluconate chelator released from the 




This is analogous to how killer T cells secrete the cytotoxic proteins in the vicinity of 
infected cells. Overall, this chapter presents the first study, to best of our knowledge, to 
explore the concept of using one polymer particle as the vehicle to destroy another 
particle. The concept could have potential applications in localized release of drugs or 
other solutes.  
 
Moreover, the killer T cell-inspired capsule concepts could have future impact in 
the larger artificial cell field. Other groups have developed simple protocells from similar  
nonbiotic components that mimic basic functions of the biological cell. For instance, the 
Bentley group has developed biopolymer capsules with the ability to communicate and 
participate in biological signaling through small molecules.12 In addition, others have 
made cell membrane-mimetic barriers on capsules through coating of polymer capsules 
with phospholipids.100 Also, functions associated with specific types of cells have been 
mimicked through protocells: the DeSimone group designed polymer microparticles that 
are shaped like red blood cells and  have the ability to transport hemoglobin.101 As the 
emerging protocell field matures, new cell-like functionalites for microparticles/capsules, 
such as targetted degradation, could be useful for development of more sophisticated 
protocells with even greater cell-like functionalities.  
 
5.2 EXPERIMENTAL SECTION 
Materials and Chemicals. Chitosan (medium molecular weight; degree of deacetylation 
≈ 80 %), sodium alginate (low viscosity, 1 wt% ≈  5-40 cP; molecular weight 110–150 




glucose oxidase (GOx) from Aspergillus niger (100000 units/g), D-glucose, sodium 
gluconate, pluronic F-127, copper (II) sulfate, strontium chloride hexa-hydrate, and 
HEPES were obtained from Sigma-Aldrich. Green-fluorescent latex nanospheres (100 
nm) were obtained from Polysciences Inc. (Cat# 17150).  
 
Synthesis of Target Beads. Target beads were produced by cross-linking alginate 
droplets with copper ions. Using a syringe pump (1 mL/min), the alginate solution (2 
wt% in DI water) was extruded through a 22 gauge needle to generate droplets that were 
collected in an aqueous solution of 1 wt% copper sulfate (with 0.3 wt% Pluronic F127 
added as a surfactant) and allowed to crosslink for 30 min. The copper-alginate beads 
were then washed in DI water (5 times) and stored at 4°C in DI water. For entrapment of 
the fluorescent nanoparticles, the alginate solution was combined with the fluorescent 
latex nanospheres (0.2 wt%), prior to bead formation. 
 
Synthesis of Killer Capsules. The “killer” chitosan capsules were generated by 
immobilizing GOx within a chitosan-TPP matrix. GOx enzyme (200 units/mL) was 
dispersed in chitosan solution (2 wt% in DI water) and using a syringe pump (1 mL/min), 
was extruded through a 22 gauge needle to generate droplets that were collected in a TPP 
solution (10 wt% in acidified water; pH = 5) and allowed to crosslink for 30 min. The 
chitosan-TPP beads were then incubated in a glutaraldehyde solution (1 wt% in DI water) 
for 1 h to immobilize the GOx enzyme, as recommended in other studies.102,103 Next, the 





For micron-sized killer chitosan capsules, a pulsed gas-flow microcapillary device 
designed by Oh et. al was adapted for use.104 The chitosan solution (2 wt%) was pumped 
(1.5 L/min) through a silica capillary (diameter ≈ 100 m) and pulses of gas (3 Hz; 9 psi) 
were controlled by a digital gas flow controller. Chitosan droplets with dispersed GOx 
(200 units/mL) were then collected in an aqueous TPP solution for 30 min (10 wt%), then 
incubated in glutaraldehyde (1 wt%) for 1 h, washed in DI water (5 times), and stored at 
4°C in DI water.  
 
Bead Degradation Experiments. For the experiments in Figure 5.3 (degradation through 
direct addition of GOx enzyme), the target copper-alginate bead was placed in 1 mL of 
HEPES buffer (0.02 M; pH = 7.4), which contained dissolved glucose (1 wt%). The 
negative control was the same HEPES buffer solution that did not contain any glucose. 
The GOx enzyme was added at t = 0 (working concentration of enzyme in overall 
solution was 1 unit/mL). Brightfield microscopy images (2.5X objective) were taken 
every 5 min. Similarly, for the subsequent experiments, instead of directly adding the 
GOx enzyme to initiate target bead degradation, the chitosan capsule (which contains the 
immobilized GOx) was added to the same buffered glucose solution at t = 0 of the 
respective experiment. For micron-sized degradation experiments, the populations of 
killer microcapsules, target microbeads, and inert microbeads were mixed at roughly 
equal ratios in the same buffered-glucose solution (1 wt% glucose; 0.02 M HEPES; pH = 





Optical and Fluorescence Microscopy. A Zeiss Axiovert 135 TV inverted light 
microscope equipped with ToupView Imaging software was used for brightfield 
microscopy. Beads were imaged with either a 2.5 X of 10 X objective. To observe release 
of the fluorescent latex nanospheres, fluorescent images were taken using a band pass 
excitation filter (530-585 nm) and a long pass emission filter of 615 nm.  
 
Fluorescence Measurements. Release profiles for the fluorescent nanoparticles were 
collected using five target Cu-alginate beads (which contained the nanoparticles) mixed 
with five killer chitosan capsules in a buffered-glucose solution (1 wt% glucose; 0.02 M 
HEPES; pH = 7.4; 2 mL total solution). Fluorescence intensity measurements were taken 
hourly using a Synergy HTX Multi-Mode Microplate Reader (BioTek) on aliquots (200 
L) that were removed from the surrounding solution. Following measurement of 
fluorescence intensity, the aliquots were placed back in the sample solution. Additionally, 
to allow for uniform fluorescent intensity readings, the sample was shaken on a rotary 












5.3. RESULTS AND DISCUSSION 
 
 
Figure 5.2. Schematic of proposed bead degradation method. The enzyme glucose 
oxidase (GOx) can catalyze the production of gluconate from ambient glucose (a). As a 
chemical chelator, the gluconate ions have strong interactions with the copper ion cross-
links of an alginate bead, and thereby remove the Cu2+ cross-links from the target 
alginate bead, resulting in destruction of the alginate bead (b).  
 
We formed alginate beads by introducing sodium alginate into a solution of the 
multivalent metal cation, Cu2+.105 These beads are susceptible to degradation through 
exposure to Cu2+ chelators such as gluconate, as described in Chapter 2.106 Here, we will 
use enzymes to generate the gluconate. The enzyme chosen is glucose oxidase (GOx), 
which converts D-glucose to gluconate in the presence of water and oxygen, as shown by 
the scheme in Figure 5.2a.106 (The intermediate D-glucono--lactone (GDL) is first 
formed from glucose, and GDL slowly undergoes hydrolysis in water to become 
gluconate; this step is omitted from the scheme for simplicity.)107 The key point in our 




lead to the chelation of the Cu2+ ions and thereby to the destruction of the Cu-alginate 
bead (Figure 5.2b).  
 
Figure 5.3. Optical microscopy images over time of an alginate microbead (cross-linked 
with copper ions) in the presence of GOx enzyme. In the presence of glucose, at t = 0, the 
glucose oxidase enzyme is added to the sample and the Cu-alginate bead degrades over 
the course of 6 hours (a). When the same experiment is conducted without glucose, the 
Cu-alginate bead remains intact, as the enzyme has no source to generate gluconate 
chelator ions (b). Scale bars: 1 mm. 
 
 The above concept was initially tested by exposing Cu-alginate beads to free GOx. 
Figure 5.3 shows optical microscopy images of this process. In the presence of glucose (1 
wt%) and free GOx (1 unit/mL), the alginate bead disintegrates over the course of 6 h. 
Conversely, with free GOx, but no glucose added, the bead remains intact because the 




conducted in HEPES buffer (a common buffer that does not interact with metal ions).108 
The buffer is needed to maintain pH, as the chelation efficiency of gluconate drops at 
lower pH. Also, we should point out the reason behind the choice of Cu2+ as the cation to 
crosslink the alginate in our studies. The reason for this is that gluconate is an effective 
chelator for Cu2+, with the stability constant for gluconate-Cu2+ chelation being 18.3. In 
comparison, the chelation efficiency is much lower for gluconate with Ca2+ and Sr2+ (two 
cations that are commonly used to crosslink alginate), with the stability constants for the 
latter being only about 1 (see Table 2.1 in Chapter 2). As a result, the GOx/glucose 
reaction is effective at degrading Cu-alginate beads, but not Ca-alginate or Sr-alginate 
ones.     
 
Figure 5.4. Preparation of killer chitosan capsules. The enzyme (GOx) is dispersed in a 
cationic polymer solution (chitosan) and a syringe pump generates droplets, which are 
collected in a cross-linking solution containing the anion, tripolyphosphate (TPP). The 
chitosan droplets are cross-linked into a solid hydrogel capsule by the TPP molecules, 
which results in immobilized enzymes within the chitosan capsule.  
 
Having demonstrated that the GOx enzymatic reaction can destroy Cu-alginate 




were made by an alternative chemistry, i.e., using the cationic polymer, chitosan, the 
multivalent anion, TPP, and the chemical crosslinker glutaraldehyde.103,109,110 First, GOx 
enzyme (200 units/mL) was added to a chitosan solution and droplets of this solution 
were collected in a solution of TPP. Electrostatic interactions between the cationic 
chitosan and the anionic TPP result in the conversion of the droplets into soft 
capsules/gels.111 To further strengthen the chitosan-TPP particles, they were exposed to 
glutaraldehyde.102,103 This gives us stable “killer” capsules with the GOx in their lumen.  
 
 
Figure 5.5. Schematic of killer chitosan capsule with encapsulated glucose oxidase 
(GOx) that targets neighboring Cu-alginate beads. Ambient glucose diffuses into the 
killer capsule, wherein, immobilized GOx enzyme converts glucose to gluconate ions, 
which diffuses out and targets neighboring Cu-alginate beads, resulting in destruction of 
the neighboring alginate bead. 
 
Overall, the action of the killer capsules (bearing GOx) on their target Cu-alginate 
beads is conceptualized in Figure 5.5. Dissolved glucose from the surroundings diffuse 
into the killer capsule, where the glucose is catalyzed by the GOx enzyme and converted 




neighboring target Cu-alginate bead. As the gluconate molecules diffuse into the bead, 
they chelate the Cu2+ ions, which form the crosslinks in the bead. Thereby, the target 
bead is degraded into soluble alginate chains. To test this concept, we conducted the 
experiment shown in Figure 5.6. Here, the killer capsule has an orange color while the 
target Cu-alginate bead is blue-green (both structures have diameters around 2.5 mm). 
The two are placed in a buffered solution containing 1 wt% glucose. As expected, the 
alginate bead is observed to degrade over a period of 18 h, which is due to loss of its Cu2+ 
crosslinks.   
 
 
Figure 5.6. Visual observations depicting the degradation of a target Cu-alginate bead in 
the presence of a GOx loaded killer chitosan capsule. At t = 0, the killer capsule and 
target bead are placed together in a buffered glucose solution; Over the course of 18 
hours, the target bead is completely destroyed. Scale bars: 5 mm. 
 
Targeted bead degradation in the above manner could be useful for localized 
release of trapped cargo from the beads. We sought to demonstrate this by encapsulating 
fluorescent nanoparticles (≈ 100 nm) within the target Cu-alginate bead matrix. In Figure 
5.7, a killer chitosan capsule was placed near a target bead containing the nanoparticles, 
both were placed in a buffered 1 wt% glucose solution, and the system was visualized by 




the fluorescence is confined to the bead volume. However, as the Cu2+ crosslinks are 
removed from the Cu-alginate bead, the nanoparticles get released into the surrounding 
solution. We thus see the emergence of background fluorescence in the solution once the 
bead is sufficiently degraded.  
    
 
Figure 5.7. Fluorescent microscopy images demonstrating release of fluorescent 
nanoparticles from a degrading Cu-alginate bead. At t = 0 the killer chitosan capsule was 
placed next to the target Cu-alginate bead. The top row of optical microscopy images 
depicts destruction of the target bead by the killer capsule and the corresponding 
fluorescent images in the bottom row depict the release of fluorescent particles as the 






Figure 5.8. Quantifying release of fluorescent nanoparticles from a target alginate-copper 
bead. Using a plate reader, relative fluorescent intensities were measured hourly from 
aliquots of the surrounding solution. Target Cu-alginate beads exposed directly to pure 
chelator (sodium gluconate) quickly dissolved (within 1 hr) and released the fluorescent 
particles into the surrounding solution. Samples containing the killer chitosan capsules 
slowly degraded and the fluorescent intensity of the surrounding solution steadily 
increased. Negligible relative fluorescent intensity values were detected for the negative 
control (fluorescent target beads alone in buffer solution) indicating that the fluorescent 
nanoparticles cannot leak out of intact Cu-alginate beads. Error bars for each point 
represent one standard deviation among 5 runs. 
 
To quantify release of fluorescent nanoparticles from Cu-alginate beads, the 
experimental design from Figure 5.7 was repeated under gentle stirring. Aliquots of the 
surrounding solution were analyzed over time to measure the background fluorescence. 
The results are represented in Figure 5.8. The negative control here is Cu-alginate beads 
with fluorescent nanoparticles in glucose-buffer solutionhere there is no degradation 




alginate beads with fluorescent nanoparticles were exposed to pure chelator (sodium 
gluconate)in this case, the beads degraded completely within 1 h, releasing their 
fluorescent payload into the solution. The intermediate case is when killer chitosan 
capsules are added to the target beads. In this case, the target beads are destroyed over a 
period of several hours. Over this time, the fluorescent nanoparticles will be increasingly 
released into solution, and as a result, we find a monotonic increase in fluorescence 
intensity until it plateaus at a value close to that of the positive control.  
 
 
Figure 5.9. Preparation of killer chitosan microcapsules using a pulsed gas flow device. 
Smaller microdroplets, which results in smaller microcapsules, were generated by 
flowing the chitosan solution through a microcapillary (diameter ≈ 100 m) and coaxial 
pulses of gas (regulated by a digital gas flow controller) sheared the chitosan solution into 
micron-sized droplets that were collected in a TPP cross-linking solution, resulting in 
cross-linked microcapsules. GOx enzyme was dispersed in the chitosan solution to 
generate killer chitosan capsules, similar to Figure 5.4.   
 
The above experiments with killer and target particles were conducted using large 




particles). To create smaller counterparts of our particles, a method developed recently in 
our lab to form microdroplets104 was adapted (Figure 5.9). Briefly, a digital gas flow 
controller connected to a function generator was used to regulate pulses of nitrogen gas, 
which sheared aqueous chitosan droplets (containing dispersed GOx enzyme) from a 
glass micro-capillary (diameter ≈ 100 m). Similar to Figure 5.4, the chitosan droplets 
were introduced into aqueous TPP and then combined with glutaraldehyde to give killer 
microcapsules with encapsulated GOx enzyme. The same method was used to form 
aqueous droplets of sodium alginate, which were then added to a Cu2+ solution to form 
target Cu-alginate microbeads.  

 
Figure 5.10. Optical microscopy images depicting degradation of a target Cu-alginate 
microbead by a neighboring killer chitosan microcapsule over the course of 5 hours. 
Scale bars: 200 µm. 
 
We tested the killer microcapsules against the target microbeads (both have 




As before, the target Cu-alginate bead gets destroyed over the course of 5 h by its 
neighboring killer chitosan microcapsule. We found that the degradation is more rapid 
when the target microbead is very close to a killer microcapsule. In comparison, target 
microbeads that are relatively far from a killer microcapsule degrade more slowly. This 
shows the local nature of the destruction and is due to the fact that it relies on diffusion of 
the gluconate chelator from the killer to the target.  
  
For a final proof-of-concept demonstration, we wanted to show specificity in 
destruction of target microbeads by the killer capsules. In the immune system, killer T 
cells destroy virus infected cells whereas they leave healthy bystander cells alone. To 
show this, we synthesized three different populations of microparticles, and their mixture 
in roughly equal numbers is shown in Figure 5.11a. One population is of killer chitosan 
microcapsules (diameter ≈ 300 µm), another population is the Cu-alginate target beads 
(diameter ≈ 300 µm), and the third population is composed of inert chitosan beads from 
Chapter 4 with encapsulated carbon black (diameter ≈ 150 µm). As time progresses, only 
the target Cu-alginate beads susceptible to the chelator are destroyed, as shown in Figure 
5.11b and 5.11c. At the end of the experiment (Figure 5.11c), only two sets of particles 






Figure 5.11. Optical microscopy images depicting selective degradation amongst 3 
population sets of microparticles. One set of particles is comprised of killer chitosan 
capsules, another population contained the target Cu-alginate beads, and the third 
population was composed of black inert chitosan beads used in previous chapters. Due to 
selective targeting by the killer capsule, only two sets of particles (inert black beads and 
killer chitosan capsules) remained at the end of the experiment. Scale bars: 200 µm. 
 
5.4. CONCLUSIONS 
We have shown development of killer T cell inspired chitosan capsules. This was 
done by immobilizing the glucose oxidase enzyme within the chitosan capsule. Glucose 
molecules in the surrounding solution are converted into gluconate ions by the GOx 
enzyme within the killer capsule. The gluconate molecules remove the copper ions (Cu2+) 
that cross-link a neighboring alginate bead, resulting in target bead destruction. To 
support this, we first demonstrated that direct addition of the GOx enzyme, in the 
presence of glucose (the substrate), can cause degradation of a Cu-alginate bead. 
Additionally, it was confirmed that the presence of both glucose and GOx were necessary 




killer chitosan capsule and observed killer capsule initiated destruction of Cu-alginate 
beads on two different size scales. Finally, the potential of this bead degradation system 
for release of cargo was demonstrated through encapsulation of fluorescent nanoparticles 
within the target bead. Upon degradation of the target Cu-alginate bead, the release of the 
fluorescent nanoparticles was visualized using fluorescent microscopy and quantified 










CONCLUSION AND RECOMMENDATIONS 
 
6.1. PROJECT SUMMARY AND PRINCIPAL CONTRIBUTIONS   
In this dissertation we have shown three new concepts for engineering 
microparticles with bio-inspired functionalities. Each chapter focused on designing 
microparticles to have customized interactions with their surroundings as inspired by 
biological cells. Microparticle analogues were designed to demonstrate (1) selective 
adherence to surfaces (essential for pathogen identification by immune cells); (2)   
stimulus based clustering (necessary in blood clot formation by platelet cells) and (3) 
selective destruction of neighboring microparticles (inspired by killer T cells).  
 
In Chapter 3, we functionalized chitosan microbeads with streptavidin that 
allowed for recognition and selective adherence to specific types of biological cells. 
Additionally, using simple commercially available microtubing, we developed bulk 
generation methods for the functionalized chitosan microbeads to allow for an 
inexpensive platform to conduct in-house customized cell capture studies. Moreover, 
through encapsulation of carbon black within the chitosan microbeads, we addressed a 
major barrier (intrinsic autofluroescence) towards implementation of chitosan microbeads 
in quantative cell capture and detection studies.  
 
In Chapter 4, we created a unique stimulus-based microbead clustering system 




chitosan microbeads from Chapter 3 are functionalized with cyclodextrins to embed cell 
membrane-like hydrophobic pockets, which resulted in rapid microbead clustering 
(similar to “platelet plugs”) upon recognition of an associating polymer (hm-chitosan). 
After initial clustering, the hm-chitosan polymer precipitates around the cluster and traps 
surrounding bystander microbeads in the polymer web. This hm-chitosan bead-polymer 
matrix (analgous to a fibrin-cell blood clot) was strong enough to transport captured 
bystander beads to desired locations. Such bio-inspired, stimulus-induced microbead 
clusters could be useful in embolization and bulk transport of micron-sized objects.   
 
In Chapter 5, we describe development of killer chitosan microcapsules that can 
locally and selectively destroy neighboring alginate beads that were cross-linked with 
Cu2+. Chitosan microcapsules are functionalized by encapsulating GOx enzyme, which 
allows for secretion of gluconate ions that remove Cu2+ cross-links from the target 
alginate bead. This results in chitosan microcapsules that can selectively destroy 
neighboring Cu-alginate beads. To the best of our knowledge, this was the first study to 
explore the concept of using one polymer particle as the vehicle to destroy another 
particle. Additionally, this was the first reported use of an enzyme to generate chelators 
for destruction of a metal cross-linked alginate bead. The findings in this Chapter could 







6.2. RECOMMENDATIONS FOR FUTURE WORK 
6.2.1. Future Work with Microparticles Presented in this Dissertation  
It would be useful to combine functionalities demonstrated in the previous 
chapters to make even smarter and more cell-like microparticles. In Chapter 3, we 
described the functionalization of chitosan beads to selectively adhere to target surfaces 
through biotin-streptavidin interactions, while in Chapter 5, we described development of 
killer chitosan capsules that can selectively destroy neighboring alginate beads. To 
further add functionality and more closely mimic killer T cells, an exciting future study 
would be to combine the strepavidin-biotin binding system with the killer chitosan 
capsules from Chapter 5. Ideally, these new killer chitosan microcapsules, in additon to 
encapsulation of GOx enzyme, would have streptavidin molecules on their surface, while 
the payload carrying alginate bead would be modified with biotin molecules; this would 
allow selective adhesion of the killer chitosan capsules to only the target alginate beads, 
prior to target bead degradation. For this potential future study, alginate could be 
chemically modified with biotin, prior to cross-linking copper ions, as shown by 
others.112  
 
In addition it would be very interesting to combine the microbead assembly 
system demonstrated in Chapter 4 with the bead degradation functionalities presented in 
Chapter 5. In Chapter 4, we demonstrated assembly of a bead-polymer matrix that can 
trap and transport surrounding bystander microbeads to desired locations. Interesting 




beads from Chapter 5, where nearby killer chitosan capsules could initiate release of the 
cargo through chelator based degradation.  
 
Finally, each cell-inspired microparticle system presented in this dissertation 
employed microparticles ranging from 100-300 microns in size. That size scale was 
convenient, due to easily accesible commercial microtubing for microparticle synthesis, 
and useful for initial proof-of-concepts studies as shown in this dissertation; however, 
biological cells are an order of magntiude smaller in size ≈ 10-20microns. Interesting 
future studies would be to apply the cell-inspired microbead systems presented in 
previous chapters with technologies that allow for synthesis of the microparticles at even 
smaller scales, closer to actual sizes of cells.  One such technology is through use of 
pulled glass microcapillaries as presented by the Weitz group.113,114 Overall, future 
studies to demonstrate concepts from this dissertation using smaller microparticles could 
be very interesting.    
 
6.2.2. Red Blood Cell Shaped Microparticles 
In addition to the microparticle analogues presented in this dissertation, new types 
of microparticles could be designed to mimic other types of specialized biological cells. 
For instance, microparticles mimicking the biconcave shape of red blood cells have been 
explored in other studies.101,115,116 Generally, on the micron scale, controlling the shape of 
the polymer particles is a challenge due to the effects of surface tension, which favor 
spherical morphologies.117 Thus, an additional “manufacturing” step to control shape is 




anisotropic microparticles could be generated through controlled solidification of a 
polymer droplet in a microfluidic device.117 Their microfluidic system can yield red 
blood cell shaped microparticles from various synthetic polymers such as polysulfone, 
polymethyl methacrylate, and polyvinylidene fluoride. Alternatively, the DeSimone 
group generates biocompatible red blood cell shaped microparticles from biopolymers 
and have found that tuning their shape and elasticity can affect their biological retention 
time, when intravenously injected into mice.118 However, the DeSimone group uses 
prefabricated molds (Print®) for generation of biocompatible biopolymer based particles. 
Additional studies adapting the red blood cell shaped particles in a microfluidic 
generation system for biopolymers could be useful.  
 
  
Figure 6.1.  Images of red blood cell shaped alginate microparticles from: (a) optical 
microscopy; and (c) SEM. In (b) the size distribution of microparticles in (a) is plotted. 
The average diameter is 111.5 m with a relative standard deviation of 4.8% (n = 100). 
The solid line in (b) is a Gaussian fit to the data.  
 
We conducted preliminary experiments where red blood cell shaped alginate particles 
were created through a simple microfluidic process. First, aqueous droplets of alginate 
were generated in a microfluidic device through shearing by a continuous oil phase 




stream) were then collected in an ethanol solution, resulting in precipitation of the 
alginate droplet into red blood cell shaped alginate particles as shown in Figure 6.1. 
Future studies further exploring the mechanism for shape transformation in this alginate 




















DETAILED PROCEDURES MICROBEAD SYNTHESIS 
 
Two phase flow (continuous oil phase and dispersed aqueous phase) was used to generate 
chitosan droplets in a tubing device manufactured from commercial fittings and tubing. 
The chitosan droplets were converted into solid chitosan microbeads upon collection into 
an oil solution containing the cross-linker glutaraldehyde (GA). A washing procedure 
was developed to provide stable transfer of the chitosan beads into aqueous solutions. A 
detailed procedure is provided below.    
 
1) Construction of the Tubing Device 
1.1) Cut out small length (≈6.5 cm) of silica tubing (≈150 μm inner diameter / 220 μm 
outer diameter ) and attach Luer Lock fittings to the Luer Tee. 
1.2) Insert silica tubing through the Luer Tee and have roughly an even amount of silica 
tubing exposed on each side (≈1.0 cm) of the Luer Tee.     
1.3) From one end, insert the PTFE (≈300 μm) tubing over the exposed silica tubing 
(without changing the position of the silica tubing in the Luer Tee), until the PTFE tubing 
is halfway through the Luer Tee. 
1.4) Use 5 minute epoxy to seal both ends of the Luer Tee, on the orifice of the Luer 
Lock fittings  
1.5) Connect the Tygon tubing over the other two Luer Lock orifices on the Luer Tee.  
The tubing device is designed for the aqueous phase to flow through the silica capillary, 
where it will meet a faster flowing oil stream at the end of the silica capillary (which is 
inside the PTFE tubing, but outside the Luer Tee). The droplets are generated at this 
location and the size of the droplets correlates to the inner diameter of the PTFE tubing. 
The oil phase will enter through the perpendicular orifice on the Luer Tee and completely 
fill the Luer Tee body without interacting with the aqueous phase (which is inside the 
silica capillary), until it exists towards the PTFE tubing where it will meet the aqueous 






2) Generation of Chitosan Beads using the Tubing Device 
2.1) Prepare an aqueous 2 wt% chitosan (pH 5.5) solution and load the solution into a 5 
mL plastic syringe.  
2.2) Prepare a second solution with 2 wt% SPAN 80 in Hexadecane and load into a 20 
mL plastic syringe. 
2.3) Tap both syringes to remove all bubbles. As the chitosan solution is more viscous, 
significantly longer tapping may be required to remove the bubbles.     
2.4) Connect the chitosan solution syringe to a female Luer Lock fitting and then connect 
that fitting to the tygon tubing, which is connected to the tubing device. Prepare the same 
connections between the oil solution syringe and the tubing device. Lock in the two 
syringes on two separate syringe pumps. 
2.5) Pump the hexadecane containing syringe at 30 L/min and the syringe containing 
chitosan at 2 L/min (we are running the solutions at higher flow rates initially to quickly 
reach the maximum pressure buildup within the device for equilibrium droplet generation) 
until all the air bubbles have been eliminated and the first chitosan droplets are generated. 
These first chitosan droplets can be collected in a vial containing hexadecane with 2 wt% 
Span 80. 
2.6) Lower the syringe pump rates to 10 L/min (oil solution) and 0.33 L/min (aqueous 
chitosan solution). The settings at 10 L/min (oil solution) and 0.33 L/min (aqueous 
chitosan solution) will be the final steady state settings for generation and collection of 
droplets. Run the system at these rates for at least 45 minutes. Check that the droplets are 
being generated at a steady state (the droplets should be flowing at a constant rate 
throughout the 300 micron tube) before collecting the droplets in the cross-linking 
solution. 
2.7) Put outlet of tubing device (PTFE tubing) into the cross-linking solution (2% by 
volume Glutaraldehyde, 2 wt% Span 80, in Hexadecane), with mild mixing conditions 
(200-500 RPM) using a magnetic stir bar such that the droplets are mixing throughout the 
collection container before settling.  
 
Droplets can be collected for approximately 20 hours without the need to refill the 
syringes or worrying about overflowing the collection vial. Once the desired amount of 
droplets is generated, remove the tubing from the collection container as well as the stir 





Figure A1. Microfluidic tubing device setup for the generation of chitosan microbeads. 
The 5 mL syringe (top) is loaded with the chitosan solution and the 20 mL syringe 
(bottom) is loaded with the oil solution. The collection vial, placed at the center of the stir 
plate, contains the cross-linking solution, which turns turbid when the glutaraldehyde is 
dispersed in the oil. The tip of the PTFE tubing is submerged in the GA solution, but 
should be held close to the surface of the liquid (i.e. it should not be in contact with the 
bottom or the walls of the vial). 
 
3) Washing Procedure for the Chitosan Beads 
Before using the chitosan beads in aqueous buffers, it is suggested to conduct a series of 
solvent exchange steps to transfer the dispersed beads from the oil-based GA solution to 
an aqueous buffer. The first step is to remove the residual GA and water surrounding the 
beads via nitrogen gas evaporation. 
3.1) Transfer all the beads within the collection solution to various small glass vials (≈ 5 
mL). 
3.2) Wait for the beads to settle to the bottom of the container (≈ 1-2 minutes) as shown 





Figure A2. Chitosan microbeads in the cross-linking solution (2 wt% Span 80, 2 % by 
volume glutaraldehyde in hexadecane) after a five-day storage period. The beads are 
allowed to settle to the bottom before removing most of the cross-linking solution.  
 
3.3) Remove the collection solution (all but 1 mL as shown in Figure A3a) and replace it 
with pure 1-decanol. Fill half of the vial with 1-decanol; otherwise, the vial will overflow 
once N2 is added. 
3.4) Air the 1-decanol and beads mixture with nitrogen gas for 3 hours to evaporate the 
GA and water in the solution. To deliver the nitrogen gas (1-2 psi), insert the degassing 
needle into a plastic transfer pipette before placing it in the vial (Figure A3). This method 
will help create a broader and stronger convection current and will allow the beads to 
float freely in the solution. Remember to tape the vial to a stable surface to avoid spilling 










Figure A3. Picture a) shows the vial of beads after removing the cross-linking solution 
and before adding the pure 1-decanol. After approximately half of the vial containing the 
beads is filled with 1-decanol, the transfer pipette is placed in the vial (b). Then, the vial 
is taped to the supporting platform and the nitrogen gas valve is opened (1-2 psi). Adding 
nitrogen gas to the solution will create convection and air bubbles (b). The configuration 
of the needles (covered with plastic transfer pipettes) that deliver the nitrogen gas is 
illustrated in both pictures.  
 
3.5) After the degasification process, transfer the beads to larger vial (≈30 mL) and then 
remove the existing 1-decanol solution. Replace this solution by filling the vial with fresh 
1-decanol. This solvent exchange process will be considered a single wash. Any further 
references to washing of the chitosan beads in the protocol will refer to allowing beads to 
settle and replacement of the existing solution with the stated new solution. 
3.6) Repeat the 1-decanol wash one more time and then sequentially wash the beads with 
ethanol (3 times) and water (3 times). 
After performing this washing procedure, the beads can be stored in aqueous solutions, 
where they will remain stable and dispersed as individual beads over time. For maximum 
stability in aqueous solution (≈ 2 years), functionalize the beads with streptavidin as 
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